We advise on the legal risks and compliance issues arising from the development, deployment, and commercialization of humanoid robots, bionic devices, and AI-powered interactive terminals. Our services support clients working in R&D, manufacturing, platform integration, and consumer-facing applications—whether operating in China or preparing for cross-border rollout.

R&D and Commercialization Agreements

• Technology collaboration and IP allocation

  We draft and negotiate joint R&D agreements for hardware and software, clarifying ownership of inventions, licensing terms, and benefit-sharing mechanisms.

• Training data compliance

  We assess the collection, processing, and reuse of training data to ensure legality under Chinese privacy and cybersecurity laws.

Algorithmic Functionality and Ethics

• Compliance for human-like interaction

  We advise on legal and ethical risks related to functions such as emotional recognition, behavioral modeling, and autonomous decision-making, and assist clients in preparing internal risk disclosures and ethics statements.

• Content and platform responsibility

  We help clients identify risks such as deepfakes, defamation, or infringement related to AI-generated content, including guidance on portrait rights, misinformation, and content moderation obligations under Chinese law.

Product Compliance and Consumer Protection

• Product liability risk assessment

  We evaluate legal risks from hardware malfunctions, algorithmic misjudgments, or user harm scenarios, and assist in implementing mitigation strategies.

• Digital persona and labor law boundaries

  We provide legal opinions on the boundaries between “virtual employees” and human workers, including disputes over replacement, performance expectations, and labor law triggers.

• Pre-market compliance review

  We conduct legal reviews prior to product launch, covering safety certifications, user instructions, mandatory labeling, and compliance statements.

• Incident response and public crisis management

  We support clients in responding to consumer complaints, administrative investigations, product recalls, and reputational crises involving high-profile AI products.

Medical Device and IP Strategy

• Compliance for bionic medical devices

  We advise on regulatory classification, clinical pathway design, and registration of bionic devices that fall within the scope of China’s medical device laws.

• Intellectual property protection and licensing

  We assist in securing patent rights, safeguarding trade secrets, and structuring licensing deals for technologies used in humanoid systems.